Creative Medical Technology Holdings, Inc. (CELZ) earnings per share
Annual history
Fiscal years 2020 – 2025
USD / SHARE 6 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| FY 2025 | 2025-12-31 | -$2.52 | 2026-03-20 |
| FY 2024 | 2024-12-31 | -$3.71 | 2025-03-14 |
| FY 2023 | 2023-12-31 | -$3.76 | 2024-03-22 |
| FY 2022 | 2022-12-31 | -$9.30 | 2023-03-31 |
| FY 2021 | 2021-12-31 | $56.10 | 2022-03-30 |
| FY 2020 | 2020-12-31 | -$626.90 | 2021-03-17 |
Quarterly history
Fiscal years 2011 – 2026
USD / SHARE 26 PERIODS
| Period | End | Diluted | Filed |
|---|---|---|---|
| Q1 2026 | 2026-03-31 | -$0.38 | 2026-05-08 |
| Q4 2025 | 2025-12-31 | -$0.80 | 2026-03-20 |
| Q3 2025 | 2025-09-30 | -$0.48 | 2025-11-07 |
| Q2 2025 | 2025-06-30 | -$0.48 | 2025-08-08 |
| Q1 2025 | 2025-03-31 | -$0.83 | 2025-05-09 |
| Q4 2024 | 2024-12-31 | -$1.12 | 2025-03-14 |
| Q3 2024 | 2024-09-30 | -$0.75 | 2024-11-08 |
| Q2 2024 | 2024-06-30 | -$1.11 | 2024-08-09 |
| Q1 2024 | 2024-03-31 | $0.73 | 2024-05-10 |
| Q4 2022 | 2022-12-31 | -$5.30 | 2023-03-31 |
| Q3 2022 | 2022-09-30 | -$0.70 | 2022-11-10 |
| Q2 2022 | 2022-06-30 | -$2.00 | 2022-08-12 |
| Q1 2022 | 2022-03-31 | -$1.80 | 2022-05-13 |
| Q4 2021 | 2021-12-31 | -$41.60 | 2022-03-30 |
| Q3 2021 | 2021-09-30 | -$7.50 | 2021-11-15 |
| Q2 2021 | 2021-06-30 | -$12.50 | 2021-08-16 |
| Q1 2021 | 2021-03-31 | $111.80 | 2021-05-17 |
| Q4 2020 | 2020-12-31 | -$637.60 | 2021-03-17 |
| Q3 2020 | 2020-09-30 | $1.40 | 2020-11-13 |
| Q2 2020 | 2020-06-30 | -$50.00 | 2020-08-14 |
| Q1 2020 | 2020-03-31 | $0.00 | 2020-05-15 |
| Q3 2019 | 2019-09-30 | $0.00 | 2019-11-14 |
| Q2 2019 | 2019-06-30 | -$50.00 | 2019-08-13 |
| Q1 2019 | 2019-03-31 | -$600.00 | 2019-05-20 |
| Q2 2011 | 2011-06-30 | — | 2011-08-25 |
| Q2 2011 | 2010-06-30 | — | 2011-08-25 |
Methodology
Annual rows come from the filer's 10-K and Q1–Q3 rows from the matching 10-Q; Q4 is derived as full-year minus nine-month YTD because XBRL doesn't tag Q4 as its own period. EPS Basic and EPS Diluted are reported directly by the filer. Per-share values are split-adjusted to the current share count (3 split s since 2020).
For the exact XBRL concepts and formulas, see the methodology reference for EPS, FCF per share, the Q4 derivation, and split adjustment.
CELZ CIK 0001187953 Source: EDGAR filings · all facts